(Q46020755)

English

Chronic administration of infliximab (TNF-α inhibitor) decreases depression and anxiety-like behaviour in rat model of chronic mild stress.

scientific article published on 19 January 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23167806

Chronic administration of infliximab (TNF-α inhibitor) decreases depression and anxiety-like behaviour in rat model of chronic mild stress. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23167806

object named as

Fuat Balci

4

0 references

author name string

Ayşe Karson

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23167806

Tuğçe Demirtaş

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23167806

Dilek Bayramgürler

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23167806

Tijen Utkan

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23167806

publication date

19 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23167806

Basic and Clinical Pharmacology and Toxicology

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23167806

112

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23167806

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23167806

335-340

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23167806

The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Glucocorticoids, cytokines and brain abnormalities in depression

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

A meta-analysis of cytokines in major depression

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Cytokine-associated emotional and cognitive disturbances in humans

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Cytokine-induced changes in mood and behaviour: implications for 'depression due to a general medical condition', immunotherapy and antidepressive treatment

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Cytokines and psychopathology: lessons from interferon-alpha

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Th1, Th2, and Th3 cytokine alterations in major depression

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Comorbid depression in rheumatoid arthritis: pathophysiology and clinical implications

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Psoriasis, a model of dermatologic psychosomatic disease: psychiatric implications and treatments

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Immune-to-brain signaling: how important are the blood-brain barrier-independent pathways?

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

The blood-brain barrier and immune function and dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Chronic treatment with the selective NOP receptor antagonist [Nphe 1, Arg 14, Lys 15]N/OFQ-NH 2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Pulsed light irradiation improves behavioral outcome in a rat model of chronic mild stress

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Long-lasting effects of chronic rTMS to treat chronic rodent model of depression

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Chronic antidepressant administration alleviates frontal and hippocampal BDNF deficits in CUMS rat

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Effects of octreotide in chronically mild stressed rats: possible role of immune and oxidative stress pathways

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation?

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Favorable response to subcutaneous administration of infliximab in rats with experimental colitis

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Chronic mild stress-induced anhedonia: a realistic animal model of depression

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Depression: a new animal model sensitive to antidepressant treatments

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Spike-wave discharges are necessary for the expression of behavioral depression-like symptoms

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Enriched environments influence depression-related behavior in adult mice and the survival of newborn cells in their hippocampi

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Influence of kynurenine treatment on open-field activity, elevated plus-maze, avoidance behaviors and seizures in rats

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Vagotomy attenuates the behavioural but not the pyrogenic effects of interleukin-1 in rats

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Depression: an inflammatory illness?

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Chronic treatment with nanoparticles exacerbate hyperthermia induced blood-brain barrier breakdown, cognitive dysfunction and brain pathology in the rat. Neuroprotective effects of nanowired-antioxidant compound H-290/51.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Chronic stress and antidepressant treatment have opposite effects on P-glycoprotein at the blood-brain barrier: an experimental PET study in rats

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

A trans-dimensional approach to the behavioral aspects of depression

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Coexistence of anhedonia and anxiety-independent increased novelty-seeking behavior in the chronic mild stress model of depression

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Tumour necrosis factor receptor deficiency alters anxiety-like behavioural and neuroendocrine stress responses of mice.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Lack of aggression and anxiolytic-like behavior in TNF receptor (TNF-R1 and TNF-R2) deficient mice

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12037

21 January 2018

Identifiers

10.1111/BCPT.12037

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23167806

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/23167806

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46020755&oldid=971776731"